Literature DB >> 29161469

Brief Report: Validation of a Definition of Flare in Patients With Established Gout.

Angelo L Gaffo1, Nicola Dalbeth2, Kenneth G Saag3, Jasvinder A Singh1, Elizabeth J Rahn3, Amy S Mudano3, Yi-Hsing Chen4, Ching-Tsai Lin4, Sandra Bourke2, Worawit Louthrenoo5, Janitzia Vazquez-Mellado6, Hansel Hernández-Llinas6, Tuhina Neogi7, Ana Beatriz Vargas-Santos8, Geraldo da Rocha Castelar-Pinheiro9, Rodrigo B C Amorim9, Till Uhlig10, Hilde B Hammer10, Maxim Eliseev11, Fernando Perez-Ruiz12, Lorenzo Cavagna13, Geraldine M McCarthy14, Lisa K Stamp15, Martijn Gerritsen16, Viktoria Fana17, Francisca Sivera18, William Taylor19.   

Abstract

OBJECTIVE: To perform external validation of a provisional definition of disease flare in patients with gout.
METHODS: Five hundred nine patients with gout were enrolled in a cross-sectional study during a routine clinical care visit at 17 international sites. Data were collected to classify patients as experiencing or not experiencing a gout flare, according to a provisional definition. A local expert rheumatologist performed the final independent adjudication of gout flare status. Sensitivity, specificity, predictive values, and receiver operating characteristic (ROC) curves were used to determine the diagnostic performance of gout flare definitions.
RESULTS: The mean ± SD age of the patients was 57.5 ± 13.9 years, and 89% were male. The definition requiring fulfillment of at least 3 of 4 criteria (patient-defined gout flare, pain at rest score of >3 on a 0-10-point numerical rating scale, presence of at least 1 swollen joint, and presence of at least 1 warm joint) was 85% sensitive and 95% specific in confirming the presence of a gout flare, with an accuracy of 92%. The ROC area under the curve was 0.97. The definition based on a classification and regression tree algorithm (entry point, pain at rest score >3, followed by patient-defined flare "yes") was 73% sensitive and 96% specific.
CONCLUSION: The definition of gout flare that requires fulfillment of at least 3 of 4 patient-reported criteria is now validated to be sensitive, specific, and accurate for gout flares, as demonstrated using an independent large international patient sample. The availability of a validated gout flare definition will improve the ascertainment of an important clinical outcome in studies of gout.
© 2017, American College of Rheumatology.

Entities:  

Mesh:

Year:  2018        PMID: 29161469     DOI: 10.1002/art.40381

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  22 in total

1.  Effect of Dietary and Supplemental Omega-3 Polyunsaturated Fatty Acids on Risk of Recurrent Gout Flares.

Authors:  MaryAnn Zhang; Yuqing Zhang; Robert Terkeltaub; Clara Chen; Tuhina Neogi
Journal:  Arthritis Rheumatol       Date:  2019-08-01       Impact factor: 10.995

2.  Disease modification in gout: a qualitative study of gout expert rheumatologists.

Authors:  Jasvinder A Singh
Journal:  Rheumatol Adv Pract       Date:  2022-01-03

3.  Early versus Late Allopurinol Initiation in Acute Gout Flare (ELAG): a randomized controlled trial.

Authors:  Panchalee Satpanich; Wanjak Pongsittisak; Siriporn Manavathongchai
Journal:  Clin Rheumatol       Date:  2021-08-18       Impact factor: 3.650

4.  Comparative Effectiveness of Allopurinol and Febuxostat in Gout Management.

Authors:  James R O'Dell; Mary T Brophy; Michael H Pillinger; Tuhina Neogi; Paul M Palevsky; Hongsheng Wu; Anne Davis-Karim; Jeff A Newcomb; Ryan Ferguson; David Pittman; Grant W Cannon; Thomas Taylor; Robert Terkeltaub; Amy C Cannella; Bryant R England; Lindsay N Helget; Ted R Mikuls
Journal:  NEJM Evid       Date:  2022-02-03

5.  Goals of gout treatment: a patient perspective.

Authors:  Jasvinder A Singh
Journal:  Clin Rheumatol       Date:  2018-08-04       Impact factor: 2.980

6.  Risk of gout flares after vaccination: a prospective case cross-over study.

Authors:  Chio Yokose; Natalie McCormick; Clara Chen; Tuhina Neogi; Christine Chaisson; Robert Terkeltaub; David J Hunter; Yuqing Zhang; Hyon Choi
Journal:  Ann Rheum Dis       Date:  2019-07-31       Impact factor: 19.103

7.  A Randomized Internet-Based Pilot Feasibility and Planning Study of Cherry Extract and Diet Modification in Gout.

Authors:  Jasvinder A Singh; Candace Green; Sarah Morgan; Amanda L Willig; Betty Darnell; Kenneth G Saag; Rick Weiss; Gary Cutter; Gerald McGwin
Journal:  J Clin Rheumatol       Date:  2020-06       Impact factor: 3.517

8.  Sonographic estimation of monosodium urate burden predicts the fulfillment of the 2016 remission criteria for gout: a 12-month study.

Authors:  Edoardo Cipolletta; Jacopo Di Battista; Marco Di Carlo; Andrea Di Matteo; Fausto Salaffi; Walter Grassi; Emilio Filippucci
Journal:  Arthritis Res Ther       Date:  2021-07-09       Impact factor: 5.156

9.  Physical activity measured using wearable activity tracking devices associated with gout flares.

Authors:  Nada Elmagboul; Brian W Coburn; Jeffrey Foster; Amy Mudano; Joshua Melnick; Debra Bergman; Shuo Yang; Lang Chen; Cooper Filby; Ted R Mikuls; Jeffrey R Curtis; Kenneth Saag
Journal:  Arthritis Res Ther       Date:  2020-08-03       Impact factor: 5.156

10.  Monosodium urate burden assessed with dual-energy computed tomography predicts the risk of flares in gout: a 12-month observational study : MSU burden and risk of gout flare.

Authors:  Tristan Pascart; Agathe Grandjean; Benoist Capon; Julie Legrand; Nasser Namane; Vincent Ducoulombier; Marguerite Motte; Marie Vandecandelaere; Hélène Luraschi; Catherine Godart; Eric Houvenagel; Laurène Norberciak; Jean-François Budzik
Journal:  Arthritis Res Ther       Date:  2018-09-17       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.